Doug Hampton 
FLORENCIA, Italia, 23 de mayo de 2023 /PRNewswire/ — A.Menarini Diagnostics S.r.l. se complace en anunciar el lanzamiento comercial de su plataforma PRIME MDx: una plataforma de diagnóstico molecular totalmente automatizada, todo en uno y de muestra a resultado para el procesamiento de varias carteras de pruebas a través de PCR en tiempo real. La pandemia … Read more
the essential The death of the nurse attacked Monday with a knife at the CHU de Reims, is “one of the most intense dramas that can affect our nation”, reacted, this Tuesday, May 23, government spokesman Olivier Véran. “It is one of the most intense tragedies that can affect our nation”, reacts government spokesperson Olivier … Read more
FLORENCJA, Włochy, 23 maja 2023 r. /PRNewswire/ — A.Menarini Diagnostics S.r.l. z przyjemnością ogłasza wprowadzenie na rynek swojej platformy PRIME MDx: działającej w trybie „od próbki do wyniku”, kompleksowej i w pełni automatycznej platformy do diagnostyki molekularnej do przetwarzania różnych pakietów testów korzystającą z techniki PCR w czasie rzeczywistym. Pandemia COVID-19 przyniosła znaczące zmiany na rynku … Read more
ZAGREB, Croatia, May 23, 2023 /PRNewswire/ — Adria Dental Group, the largest dental group in Central and Southeastern Europe, has finalized investment in dental clinic Dentex from Zadar. Dentex is the market leader in the area of Zadar and northern Dalmatia, it employs 42 people and has 13 modernly equipped practices with its own dental laboratory. Dentex … Read more
The study points to an improvement in recovery after a heart attack. A study presented at the conference Heart Failure 2023 of the European Society of Cardiology suggests that people with strong legs are less likely to develop a heart failure after a heart attack. In France, it is estimated that 1.5 million people suffer … Read more
Leading industry expert with more than 25 years of experience in translation research in immunology BASEL, Switzerland, May 23, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to announce the appointment of Dr Annalisa D’Andrea to its board of directors as a non-executive director … Read more
LE PREMIER ESSAI CONTRÔLÉ RANDOMISÉ DE PHASE III SUR LA THÉRAPIE DE SHUNT AURICULAIRE RESTE PROMETTEUR TEWKSBURY, Massachusetts, 23 mai 2023 /PRNewswire/ — Corvia Medical, Inc, une société dédiée à la transformation du traitement de l’insuffisance cardiaque, a annoncé aujourd’hui les résultats à deux ans de son essai clinique randomisé REDUCE LAP-HF II, confirmant l’innocuité et l’efficacité soutenue du … Read more
Pioneering platform to generate novel therapies with potential to treat a wide range of diseases Financing led by Science Creates Ventures and Meltwind to fund development of the platform and initial product candidates BRISTOL, England, May 23, 2023 /PRNewswire/ — Scarlet Therapeutics (“Scarlet”), a leader in red blood cell-based therapeutics, announces today that it has … Read more
FLORENCIA, Taliansko, 23. mája 2023 /PRNewswire/ — Spoločnosť A.Menarini Diagnostics S.r.l. s potešením oznamuje komerčné spustenie svojej platformy PRIME MDx: plne automatizovanej platformy molekulárnej diagnostiky od vzoriek k výsledkom, ktorá obsahuje všetko v jednom, na spracovanie rôznych testovacích portfólií prostredníctvom PCR v reálnom čase. Pandémia Covid-19 výrazne pretvorila trh molekulárnej diagnostiky a posunula ju smerom k bezproblémovej automatizácii, … Read more
ФЛОРЕНЦИЯ, Италия, 23 мая 2023 г. /PRNewswire/ — Компания A.Menarini Diagnostics S.r.l. сообщает о коммерческом запуске своей платформы PRIME MDx, которая представляет собой универсальную, полностью автоматизированную платформу молекулярной диагностики для обработки различных тестов с использованием метода ПЦР в режиме реального времени. Пандемия COVID-19 значительно изменила рынок молекулярной диагностики, продвигая его в направлении бесперебойной автоматизации, простоты использования, … Read more